Cargando…

IL1RAP potentiates multiple oncogenic signaling pathways in AML

The surface molecule interleukin-1 receptor accessory protein (IL1RAP) is consistently overexpressed across multiple genetic subtypes of acute myeloid leukemia (AML) and other myeloid malignancies, including at the stem cell level, and is emerging as a novel therapeutic target. However, the cell-int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitchell, Kelly, Barreyro, Laura, Todorova, Tihomira I., Taylor, Samuel J., Antony-Debré, Iléana, Narayanagari, Swathi-Rao, Carvajal, Luis A., Leite, Joana, Piperdi, Zubair, Pendurti, Gopichand, Mantzaris, Ioannis, Paietta, Elisabeth, Verma, Amit, Gritsman, Kira, Steidl, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987926/ https://www.ncbi.nlm.nih.gov/pubmed/29773641 http://dx.doi.org/10.1084/jem.20180147

Ejemplares similares

Myelodysplastic Syndrome Progression to Acute Myeloid Leukemia at the Stem Cell Level
por: Chen, Jiahao, et al.
Publicado: (2018)

A myeloid tumor suppressor role for NOL3
por: Stanley, Robert F., et al.
Publicado: (2017)

Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML
por: Jasra, Sakshi, et al.
Publicado: (2021)

P488: SAFETY AND EFFICACY OF VENETOCLAX PLUS “7 + 3” CHEMOTHERAPY IN NEWLY DIAGNOSED AML
por: Mantzaris, Ioannis, et al.
Publicado: (2023)

Gluteal artery injuries including pseudoaneurysm associated with powered bone marrow biopsies
por: Singh, Aditi P., et al.
Publicado: (2017)

Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre‐leukaemic clone resulting in T2‐ALL and AML‐M0
por: Manchev, Vladimir T., et al.
Publicado: (2016)

HLX in AML: novel prognostic and therapeutic target
por: Pandolfi, Ashley, et al.
Publicado: (2012)

Satb1 regulates hematopoietic stem cell self-renewal by promoting quiescence and repressing differentiation commitment
por: Will, Britta, et al.
Publicado: (2013)

Oncogenic Roles Of A Histone Methyltransferase SETDB2 In AML1-ETO Positive AML
por: Mu, Guangfu, et al.
Publicado: (2020)

Germline RUNX1 Intragenic Deletion: Implications for Accurate Diagnosis of FPD/AML
por: Duployez, Nicolas, et al.
Publicado: (2019)

YBX1 mediates translation of oncogenic transcripts to control cell competition in AML
por: Perner, Florian, et al.
Publicado: (2021)

ENL links histone acetylation to oncogenic gene expression in AML
por: Wan, Liling, et al.
Publicado: (2017)

Lymphocyte Exhaustion in AML Patients and Impacts of HMA/Venetoclax or Intensive Chemotherapy on Their Biology
por: Zhigarev, Dmitry, et al.
Publicado: (2022)

Unveiling T cell evasion mechanisms to immune checkpoint inhibitors in acute myeloid leukemia
por: Gurska, Lindsay, et al.
Publicado: (2023)

A member of the Ras oncogene family, RAP1A, mediates antileishmanial activity of monastrol
por: Kaur, Jaspreet, et al.
Publicado: (2013)

CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3
por: Egusquiaguirre, Susana P., et al.
Publicado: (2019)

Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML
por: Valent, Peter, et al.
Publicado: (2019)

C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells
por: Klempnauer, Karl-Heinz
Publicado: (2023)

Elevated LDH greater than 400 U/L portends poorer overall survival in diffuse large B-cell lymphoma patients treated with CD19 CAR-T cell therapy in a real world multi-ethnic cohort
por: Rabinovich, Emma, et al.
Publicado: (2021)

Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells
por: Hemmati, Shayda, et al.
Publicado: (2017)

MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3′UTR
por: Johnson, Daniel T., et al.
Publicado: (2021)

Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML)
por: Mohamed, Aminetou Mint, et al.
Publicado: (2015)

Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration
por: Cappelli, Luca Vincenzo, et al.
Publicado: (2021)

COrona-rap
por: van Hogendorp, Sophie
Publicado: (2020)

Rapping Mania
Publicado: (1853)

Spiritual Rappings
Publicado: (1853)

Rapping Mania
Publicado: (1853)

In Vitro Transformation of Primary Human CD34+ Cells by AML Fusion Oncogenes: Early Gene Expression Profiling Reveals Possible Drug Target in AML
por: Abdul-Nabi, Anmaar M., et al.
Publicado: (2010)

Aberrant Bone Homeostasis in AML Is Associated with Activated Oncogenic FLT3-Dependent Cytokine Networks
por: Bär, Isabel, et al.
Publicado: (2020)

Shift of N-MYC Oncogene Expression in AML Patients Carrying the FLT3-ITD Mutation
por: Bogdanov, Konstantin, et al.
Publicado: (2023)

Rap1 and Rap2 Antagonistically Control Endothelial Barrier Resistance
por: Pannekoek, Willem-Jan, et al.
Publicado: (2013)

Large Hadron rap
Publicado: (2008)

Particle physics rap
Publicado: (2008)

Particle physics rap
Publicado: (2008)

Rap1b but not Rap1a in the forebrain is required for learned fear
por: Chen, Wen-Bing, et al.
Publicado: (2020)

Opposite functions of RapA and RapC in cell adhesion and migration in Dictyostelium
por: Jeon, Jihyeon, et al.
Publicado: (2021)

Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML
por: Nicosia, Luciano, et al.
Publicado: (2021)

19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML)
por: Lara, Joshua J., et al.
Publicado: (2022)

The Rap–RapGAP complex: GTP hydrolysis without catalytic glutamine and arginine residues
por: Scrima, Andrea, et al.
Publicado: (2008)

PB1820: CD47-BLOCKER TTI-622 COMBINED WITH AZACITIDINE IN PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA (AML) AND WITH AZACITIDINE + VENETOCLAX IN ELDERLY OR UNFIT PATIENTS WITH TP53-WILDTYPE AML
por: Daver, N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_quke64hrr83gv4ohjb45iparvo